Jump Financial’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Sell
3,900
-1,530
-28% -$858K 0.02% 890
2026
Q1
$3.05M Buy
5,430
+4,348
+402% +$2.79M 0.04% 496
2025
Q4
$732K Sell
1,082
-6,009
-85% -$4.09M 0.01% 1118
2025
Q3
$4.53M Buy
7,091
+1,559
+28% +$946K 0.05% 438
2025
Q2
$2.97M Buy
5,532
+5,032
+1,006% +$2.41M 0.03% 590
2025
Q1
$210K Sell
500
-4,988
-91% -$2.17M ﹤0.01% 1414
2024
Q4
$2.27M Buy
5,488
+3,636
+196% +$1.59M 0.05% 471
2024
Q3
$936K Sell
1,852
-2,695
-59% -$1.31M 0.02% 824
2024
Q2
$2.22M Sell
4,547
-2,867
-39% -$1.44M 0.04% 505
2024
Q1
$4M Buy
7,414
+1,464
+25% +$800K 0.11% 196
2023
Q4
$3.3M Sell
5,950
-4,009
-40% -$1.88M 0.11% 215
2023
Q3
$4.35M Sell
9,959
-4,584
-32% -$2.29M 0.16% 137
2023
Q2
$7.3M Buy
+14,543
New +$6.97M 0.27% 62
2022
Q4
Sell
-1,357
Closed -$442K 1786
2022
Q3
$442K Buy
+1,357
New +$498K 0.02% 946
2022
Q2
Sell
-1,857
Closed -$1.02M 1801
2022
Q1
$1.02M Buy
1,857
+1,052
+131% +$553K 0.04% 517
2021
Q4
$530K Buy
805
+432
+116% +$271K 0.03% 629
2021
Q3
$232K Buy
373
+9
+2% +$6.05K 0.02% 795
2021
Q2
$230K Sell
364
-315
-46% -$174K 0.02% 790
2021
Q1
$332K Sell
679
-1,121
-62% -$562K 0.03% 576
2020
Q4
$900K Sell
1,800
-65
-3% -$29.1K 0.15% 179
2020
Q3
$733K Buy
+1,865
New +$690K 0.15% 218

Other funds holding IDXX

Jump Financial's IDXX Position: Q2 2026 in Review

Jump Financial reduced its Idexx Laboratories (IDXX) stake by 28% in Q2 2026, selling an estimated $858K and leaving 3,900 shares worth $2.05M. The position accounts for 0.02% of the portfolio, ranked #890.

Jump Financial first reported a position in IDXX in Q3 2020 and has held it in 21 quarters since. The position peaked at $7.3M in Q2 2023. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Jump Financial held 3,900 shares of Idexx Laboratories worth $2.05M as of Q2 2026.
  • Jump Financial sold 1,530 Idexx Laboratories shares in Q2 2026, an estimated $858K.
  • Idexx Laboratories made up 0.02% of Jump Financial's portfolio in Q2 2026, its #890 holding.
  • Jump Financial first reported a position in Idexx Laboratories in Q3 2020 and has held it in 21 quarters since.
  • Jump Financial's Idexx Laboratories position peaked at $7.3M in Q2 2023.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.